ENPICOM releases immune repertoire sequencing analysis platform to personalise immunotherapies

On 1 August 2018, DTL partner ENPICOM announced that they have finalised development and released the first version of their ImmunoGenomiX platform to support the development, patient stratification, and treatment monitoring of immunotherapies. Read more.

This entry was posted in Partner.

Post a comment

Your email address will not be published. Required fields are marked *